GERARDI, MARIANNA ALESSANDRA
GERARDI, MARIANNA ALESSANDRA
Universita' degli Studi di MILANO
Impact of inter-observer variability on first axillary level dosimetry in breast cancer radiotherapy: An AIRO multi-institutional study
2023 M.C. Leonardi, M. Pepa, M. Zaffaroni, M.G. Vincini, R. Luraschi, S. Vigorito, A. Morra, S. Dicuonzo, G.C. Mazzola, M.A. Gerardi, M.A. Zerella, D. Cante, E. Petrucci, G. Borzì, M. Marrocco, M. Chieregato, L. Iadanza, F. Lobefalo, M. Valenti, A. Cavallo, S. Russo, M. Guernieri, T. Malatesta, I. Meaglia, M. Liotta, I. Palumbo, M. Marcantonini, E. Mezzenga, S. Falivene, C. Arrichiello, M.P. Barbero, G.B. Ivaldi, G. Catalano, C. Vidali, C. Giannitto, A. Ciabattoni, I. Meattini, C. Aristei, R. Orecchia, F. Cattani, B.A. Jereczek-Fossa
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study
2022 L. Nicosia, D. Franceschini, F. Perrone-Congedi, F. Casamassima, M.A. Gerardi, M. Rigo, R. Mazzola, M. Perna, V. Scotti, A. Fodor, A. Iurato, F. Pasqualetti, G. Gadducci, S. Chiesa, R.M. Niespolo, A. Bruni, G. Alicino, L. Frassinelli, P. Borghetti, A. Di Marzo, A. Ravasio, B. De Bari, M. Sepulcri, D. Aiello, G. Mortellaro, C. Sangalli, M. Franceschini, G. Montesi, F.M. Aquilanti, G. Lunardi, R. Valdagni, I. Fazio, G. Scarzello, L. Corti, V. Vavassori, E. Maranzano, S.M. Magrini, S. Arcangeli, M.A. Gambacorta, V. Valentini, F. Paiar, S. Ramella, N.G. Di Muzio, L. Livi, B.A. Jereczek-Fossa, M.F. Osti, M. Scorsetti, F. Alongi
Ultra-hypofractionated whole breast adjuvant radiotherapy in the real-world setting: single experience with 271 elderly/frail patients treated with 3D and IMRT technique
2022 M.A. Zerella, S. Dicuonzo, S. Frassoni, M. Zaffaroni, M.A. Gerardi, A. Morra, D.P. Rojas, S. Arculeo, L. Bergamaschi, C. Fodor, F. Emiro, C. Piccolo, V. Bagnardi, F. Cattani, V. Galimberti, P. Veronesi, R. Orecchia, M.C. Leonardi, B.A. Jereczek-Fossa
Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy
2021 M.C. Leonardi, E. Montagna, V.E. Galimberti, M. Zaffaroni, D.P. Rojas, S. Dicuonzo, M.A. Zerella, A. Morra, C. Sangalli, S. Gandini, M. Colleoni, P. Veronesi, M.A. Gerardi, D. Alterio, R. Lazzari, M. Sarra Fiore, G. Bufi, F. Cattani, F. Mastrilli, R. Orecchia, B.A. Jereczek-Fossa
Implant risk failure in patients undergoing postmastectomy 3-week hypofractionated radiotherapy after immediate reconstruction: Implant failure after breast hypofractionated radiotherapy
2021 D.P. Rojas, M.C. Leonardi, S. Frassoni, A. Morra, M.A. Gerardi, E. La Rocca, F. Cattani, R. Luraschi, C. Fodor, M. Zaffaroni, M. Rietjens, F. De Lorenzi, P. Veronesi, V.E. Galimberti, M. Intra, V. Bagnardi, R. Orecchia, S. Dicuonzo, B.A. Jereczek-Fossa
Comparing TomoHelical and TomoDirect in postmastectomy hypofractionated radiotherapy after immediate breast reconstruction
2021 S. Dicuonzo, F. Patti, R. Luraschi, S. Frassoni, D.P. Rojas, M. Zaffaroni, A. Morra, M.A. Gerardi, M.A. Zerella, F. Emiro, F. Cattani, V. Bagnardi, C.I. Fodor, P. Veronesi, V.E. Galimberti, R. Orecchia, M.C. Leonardi, B.A. Jereczek-Fossa
Mastectomy alone for pT1-2 pN0-1 breast cancer patients: when postmastectomy radiotherapy is indicated
2021 M.C. Leonardi, I.R. Scognamiglio, P. Maisonneuve, S. Dicuonzo, D.P. Rojas, M.A. Zerella, A. Morra, M.A. Gerardi, M. Zaffaroni, A. De Scalzi, A. Girardi, F. Magnoni, E. Montagna, C.I. Fodor, V.E. Galimberti, P. Veronesi, R. Orecchia, R. Pacelli, B.A. Jereczek-Fossa, G. Corso
Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients
2021 S. Dicuonzo, M.C. Leonardi, S. Raimondi, G. Corrao, V. Bagnardi, M.A. Gerardi, A. Morra, M.A. Zerella, M. Zaffaroni, F. Pansini, F. Cattani, R. Luraschi, C. Fodor, P. Veronesi, R. Orecchia, D.P. Rojas, B.A. Jereczek-Fossa
The POLO (Partially Omitted Lobe) approach to safely treat in-breast recurrence after intraoperative radiotherapy with electrons
2021 M.C. Leonardi, A. Kouloura, D.P. Rojas, M. Zaffaroni, M. Intra, P. Veronesi, A. Morra, M.A. Gerardi, C.I. Fodor, M.A. Zerella, A.M. Camarda, F. Cattani, R. Luraschi, A. Viola, G. Riva, E. Miglietta, R. Orecchia, S. Dicuonzo, B.A. Jereczek-Fossa
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients
2021 M. Buglione, D. Alterio, M. Maddalo, D. Greco, M.A. Gerardi, D. Tomasini, L. Pegurri, M. Augugliaro, G. Marvaso, I. Turturici, A. Guerini, M. Ansarin, L. Spiazzi, L. Costa, M. Cossu Rocca, S.M. Magrini, B.A. Jereczek-Fossa
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent
2020 M. Buglione, B.A. Jereczek-Fossa, M.L. Bonu, D. Franceschini, A. Fodor, I.B. Zanetti, M.A. Gerardi, P. Borghetti, D. Tomasini, N.G. Di Muzio, O. Oneta, M. Scorsetti, C. Franzese, P. Romanelli, G. Catalano, I. Dell'Oca, G. Beltramo, G.B. Ivaldi, A. Laudati, S.M. Magrini, P. Antognoni
Erratum: Correction to: Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation (La Radiologia medica (2019) 124 1 (65-78))
2020 B.A. Jereczek-Fossa, A. Surgo, P. Maisonneuve, A. Maucieri, M.A. Gerardi, D. Zerini, G. Marvaso, D. Ciardo, S. Volpe, D.P. Rojas, G. Riva, O. Alessandro, S. Dicuonzo, G. Fanetti, P. Romanelli, A. Starzynska, F. Cattani, R. Cambria, C. Fodor, C. Garibaldi, C. Romano, O. De Cobelli, R. Orecchia
Long-Term Results and Reconstruction Failure in Patients Receiving Postmastectomy Radiation Therapy with a Temporary Expander or Permanent Implant in Place
2020 S. Dicuonzo, M. Leonardi, D. Radice, A. Morra, M. Gerardi, D. Rojas, A. Surgo, V. Dell'Acqua, R. Luraschi, F. Cattani, M. Rietjens, F. De Lorenzi, P. Veronesi, V. Galimberti, G. Marvaso, C. Fodor, R. Orecchia, B. Jereczek-Fossa
Late toxicity of image-guided hypofractionated radiotherapy for prostate : non-randomized comparison with conventional fractionation
2019 B.A. Jereczek-Fossa, A. Surgo, P. Maisonneuve, A. Maucieri, M.A. Gerardi, D. Zerini, G. Marvaso, D. Ciardo, S. Volpe, D.P. Rojas, G. Riva, O. Alessandro, S. Dicuonzo, G. Fanetti, P. Romanelli, A. Starzyńska, F. Cattani, R. Cambria, C. Fodor, C. Garibaldi, C. Romanò, O. De Cobelli, R. Orecchia
HALFMOON TomoTherapy (Helical ALtered Fractionation for iMplant partial OmissiON): implant-sparing post-mastectomy radiotherapy reshaping the clinical target volume in the reconstructed breast
2019 M.C. Leonardi, R. Spoto, E. Miglietta, S. Trivellato, E. La Rocca, R. Luraschi, P. Grosso, F. De Lorenzi, C. Fodor, S. Dicuonzo, V. Dell'Acqua, M.A. Gerardi, A. Morra, C.M. Francia, M. Rietjens, V.E. Galimberti, P. Veronesi, R. Orecchia, F. Cattani, B.A. Jereczek-Fossa
Intra- and inter-observer variability in breast tumour bed contouring and the controversial role of surgical clips
2019 G. Corrao, D.P. Rojas, D. Ciardo, G. Fanetti, S. Dicuonzo, M. Mantovani, M.A. Gerardi, V. Dell'Acqua, A. Morra, C. Fodor, V.E. Galimberti, P. Veronesi, F. Cattani, R. Orecchia, B.A. Jereczek-Fossa, M.C. Leonardi
Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series
2019 M.C. Leonardi, G. Corrao, S. Frassoni, A. Vingiani, S. Dicuonzo, M. Lazzeroni, C. Fodor, A. Morra, M.A. Gerardi, D.P. Rojas, V. Dell'Acqua, G. Marvaso, F.D. Bassi, V.E. Galimberti, P. Veronesi, E. Miglietta, F. Cattani, S. Zurrida, V. Bagnardi, G. Viale, R. Orecchia, B.A. Jereczek-Fossa
Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients
2017 S. Monti, G. Palma, V. D'Avino, M. Gerardi, G. Marvaso, D. Ciardo, R. Pacelli, B.A. Jereczek-Fossa, D. Alterio, L. Cella
Urinary bladder preservation for muscle-invasive bladder cancer: a survey among radiation oncologists of Lombardy, Italy
2015 B.A. Jereczek-Fossa, R. Colombo, T. Magnani, C. Fodor, M. Alessandra Gerardi, P. Antognoni, L. Barsacchi, N. Bedini, S. Bracelli, A. Buffoli, E. Cagna, G. Catalano, S. Gottardo, C. Italia, G.B. Ivaldi, S. Masciullo, A. Merlotti, E. Sarti, M. Scorsetti, F. Serafini, M. Toninelli, E. Vitali, R. Valdagni, E. Villa, D. Zerini, O. De Cobelli, R. Orecchia
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy
2014 B.A. Jereczek-Fossa, D. Zerini, C. Fodor, L. Santoro, A. Maucieri, M.A. Gerardi, B. Vischioni, R. Cambria, C. Garibaldi, F. Cattani, A. Vavassori, D.V. Matei, G. Musi, O. De Cobelli, R. Orecchia